Posts

Just add sugar: Research shows common antioxidant can b...

New research shows that polyphenolic compounds, which are commonly found in frui...

A plant-based, oral delivery of insulin regulates blood...

Insulin production has, for the last 50 or so years, come with some risks to the...

Access to financial services linked to lower COVID mort...

New research shows that some of the best tools to decrease COVID-19 mortality ra...

A marine mystery: Discovering the link between climate...

Sea sponges are essential to marine ecosystems. They play critical roles in the ...

AstraZeneca Invests $85M in Quell for “One and Done” Ce...

AstraZeneca has entered the field of autoimmune cell therapy by partnering with ...

Cue Health racks up FDA’s first de novo nod for an at-h...

Cue Health has received the FDA’s first approval for regular use of a COVID-19 a...

Commercial Excellence Summit Brings Together Leading Mi...

This week is set to be a pivotal one in the life sciences industry. Leading mind...

Bon Secours Mercy Health And Anthem BCBS Lock Horns Ove...

Bon Secours Mercy Health is locking horns with Anthem Blue Cross and Blue Shield...

EHA 2023: Kura Oncology’s menin inhibitor ziftomenib sh...

Kura faces competition in the menin inhibitor market as the therapy is being dev...

Snap Spanish elections throw health reimbursement refor...

Two broad health reform initiatives are affected by the election.

US FDA approves Neobiosis’ IND for post-Covid syndrome ...

ViXome showed potent immunomodulatory and pro-reparative effects in pre-clinical...

FDA accepts AstraZeneca’s NDA for breast cancer combina...

The NDA submission was based on the findings of the CAPItello-291 Phase III trial.

Beacon Therapeutics enters gene therapy arena with $120...

Syncona launches its third gene therapy company to stake a claim in the ophthalm...

FDA gives Ferring go-ahead for Adstiladrin gene therapy...

Following a December approval, the FDA has now given Ferring Pharmaceuticals cle...

USPTO issues notice of allowance for Windtree’s SERCA2A...

The activators might represent both an outpatient, oral therapy for chronic hear...

US FDA approves Ironwood Pharmaceuticals’ LINZESS

The FDA approval was based on the findings obtained from a double-blind multi-ce...